Oppenheimer Asset Management Inc. Meridian Bioscience Inc Transaction History

Oppenheimer Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$23.75 - $31.69 $60,111 - $80,207	-2,531 Reduced 5.71%	41,797 $1.27 Million
Q1 2022 May 12, 2022	BUY	$19.97 - $26.94 $123,973 - $167,243	6,208 Added 16.29%	44,328 $1.15 Million
Q4 2021 Feb 02, 2022	SELL	$17.46 - $21.61 $117,732 - $145,716	-6,743 Reduced 15.03%	38,120 $778,000
Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $5,968 - $7,740	344 Added 0.77%	44,863 $863,000
Q2 2021 Aug 03, 2021	SELL	$18.01 - $28.32 $134,030 - $210,757	-7,442 Reduced 14.32%	44,519 $987,000
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $1.03 Million - $1.55 Million	51,961 New	51,961 $1.36 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.